Monthly Archives: December 2019

Organto Confirms Addition of Industry Veteran to Board of Directors

VANCOUVER, BC / ACCESSWIRE / December 10, 2019 / Organto Foods Inc. (TSXV:OGO)(OTC:OGOFF) ("Organto" or "the Company"), today confirmed the appointment of Alejandro Maldonado, an agricultural veteran in Mexico, to the Organto board of directors. The addition of Mr. Maldonado returns the board to six directors, with four independent members and two non-independent members.

Alejandro Maldonado is President and Chairman of Alpasa Farms, a strategic supply partner of Organto, and one of the largest exporters of blueberries, blackberries and figs from Mexico. Alpasa is also a strategic investor in Organto. Alejandro is the President of the Berry Growers Association of Mexico and his family has deep roots in the Mexican avocado industry, being one of the largest producers of avocados from the Michoacán region of Mexico. He is a current delegate for the Association of Producers and Packers of Avocado in Mexico (APEAM), a private, non-profit association made up of avocado exporters and packers; and the only cooperative recognized by the USDA and SAGARPA. His deep industry knowledge and supply chain expertise is expected to be an invaluable asset to Organto.

"We are very pleased to confirm Alejandro's appointment to our board as we continue our build-out our foods operations across different product lines. His knowledge of our products and supply chains combined with in-depth experience within Mexican growing regions will be invaluable for us at the board level." commented Steve Bromley, Chair and Interim CEO.

In addition, the Company announced that it has granted incentive stock options as part of its annual review to certain of its directors, officers and employees to purchase up to an aggregate of 5,325,000 common shares at an exercise price of $0.07 per share. 1,240,000 of the options vest immediately. 2,115,000 will vest after one year, 1,240,000 will vest on the second anniversary of the grant and 365,000 on the third and fourth anniversaries of the grant. All of the foregoing options expire on December 4, 2024. In addition, certain directors who were not part of the above referenced grant of stock options forfeited 3,425,000 of previously issued options.

Also, the company announced today that it will not be issuing 2,000,000 warrants that were proposed to be issued to a director as consideration for his guarantee of a credit facility (see our news release dated August 21, 2019). As a result, the Company's application to the TSX-V in this regard has been withdrawn.

ON BEHALF OF THE BOARD,

Steve Bromley
Chair and Interim Chief Executive Officer

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

For more information contact:

Investor Relations
604-634-0970
1-888-818-1364
info@organto.com

ABOUT ORGANTO

Organto's business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people and its shareholders. The Organto Foods Group is an integrated provider of year-round value-added branded organic vegetables and seasonal organic and non-GMO fruit and vegetable products using an asset-light business model to serve a growing socially responsible and health conscious consumer around the globe.

FORWARD LOOKING STATEMENTS

This news release may include certain forward-looking information and statements, as defined by law including without limitation Canadian securities laws and the "safe harbor" provisions of the US Private Securities Litigation Reform Act of 1995 ("forward-looking statements"). In particular, and without limitation, this news release contains forward-looking statements respecting Organto's business model and markets; Organto's integrated supply capabilities and plans to continue to develop and expand these capabilities; plans to expand product offerings; Organto's belief that Alejandro Maldonado's knowledge of the Company's products, supply chains and Mexican growing regions will be invaluable; management's beliefs, assumptions and expectations; and general business and economic conditions. Forward-looking statements are based on a number of assumptions that may prove to be incorrect, including without limitation assumptions about the following: the ability and time frame within which Organto's business model will be implemented and product supply will be increased; cost increases; dependence on suppliers, partners and contractual counter-parties; changes in the business or prospects of Organto; unforeseen circumstances; risks associated with the organic produce business generally, including inclement weather, unfavorable growing conditions, low crop yields, variations in crop quality, spoilage, import and export laws and similar risks; transportation costs and risks; general business and economic conditions; and ongoing relations with distributors, customers, employees, suppliers, consultants, contractors and partners. The foregoing list is not exhaustive and Organto undertakes no obligation to update any of the foregoing except as required by law.

SOURCE: Organto Foods Inc.

ReleaseID: 569717

Interlink Electronics to Present at the LD Micro Main Event (XII)

LOS ANGELES, CA / ACCESSWIRE / December 10, 2019 / Interlink Electronics (OTCPINK:LINK)-a leading multinational human machine interface (HMI) and printed electronics innovator, manufacturer, and trusted technical advisor-is proud to announce that it will be presenting at the 12th annual LD Micro Main Event tomorrow Wednesday, December 11 at 4:20 PM PST. Steven N. Bronson, President and CEO of Interlink Electronics, and Dr. Albert Lu, CTO of Interlink Electronics, will be presenting and meeting with investors.

Interlink Electronics is excited to cover recent news and share our vision and plans for the future. "With so many great things going on in our space, we have been able to lay the groundwork that will propel our success as we continue to move beyond sensors," says Mr. Bronson.

For those who want to preview the presentation, please use the following link to download a complimentary copy of the Interlink Electronics Investor Relations Presentation.

"This year's Main Event is our largest event to date, with 275 companies set to present and meet with investors," stated Chris Lahiji, President of LD Micro. "Even though LD has emerged as one of the largest and most influential organizations in the space, our focus has never deviated from showcasing some of the more interesting businesses in the world to our ever-growing community. Investor interest in our events has also never been stronger, and that goes for our commitment to philanthropy as well."

Taking place from December 10 to 12 at the Luxe Sunset Bel Air Hotel in Los Angeles, The LD Micro Main Event will feature 275 companies and be attended by over 1,400 individuals.

View Interlink Electronics' profile here: http://www.ldmicro.com/profile/LINK

Profiles powered by LD Micro – News Compliments of Accesswire

 

About Interlink Electronics

Interlink Electronics is a world-leading trusted provider of HMI, sensor, and IoT solutions. In addition to standard product offerings, Interlink utilizes its expertise in materials science, manufacturing, firmware, and software to produce in-house system solutions for custom applications. For nearly 35 years, Interlink Electronics has led the printed electronics industry in its commercialization of the patented Force Sensing Resistor® technology. Its solutions have focused on handheld user input, menu navigation, cursor control, and other intuitive interface technologies for the world's top electronics manufacturers. The company has a proven track record of supplying human machine interface solutions for mission-critical applications in a wide range of markets, including but not limited to, consumer electronics, automotive, industrial, and medical devices. Interlink Electronics serves a world-class customer base from its corporate headquarters in Camarillo, Calif., and offices in Singapore, China, and Japan.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space.

What started out as a newsletter highlighting unique companies has transformed into several influential events annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contact:
Name: Steven N. Bronson
Phone: 805.484.8855 x 444
Address: 1267 Flynn Road
Email: sb@iefsr.com

SOURCE: Interlink Electronics via LD Micro

ReleaseID: 569723

GaN Systems Showcases Smaller, Lighter, and More Efficient Power Electronics Driving Technology Innovation at CES(R) 2020

OTTAWA, ON / ACCESSWIRE / December 10, 2019 / GaN Systems, the global leader in GaN (gallium nitride) power semiconductors, today announced that it will be showcasing at Consumer Electronics Show (CES) the most recent technology innovations addressing smaller size, higher functionality, autonomy and cost saving solutions for power adapters, robots, drones, handheld electronics and electric vehicles.

(Next Generation Automotive Powered by GaN Power Electronics at CES 2020)

Looking forward in 2020 and beyond, the need for portability, autonomy and energy efficiency is increasing at a rapid pace. GaN (gallium nitride) has become an important building block for power electronics – solving design challenges, driving robust growth and innovation with products that are 4X smaller, 4X lighter, and exhibit 4X less energy loss, and enabling companies to establish and maintain leadership positions in their industries.

GaN Systems is the leader in providing the solutions required for today's power system requirements. Using GaN power semiconductors ushers in entirely new energy efficient levels and products capable of transforming the future such as bringing about lighter and longer-range electric cars, better navigation and sensing in autonomous vehicles, devices without power cords, and smaller, multi-functional power adapters.

At CES 2020, visit GaN Systems at Tech East, Renaissance Hospitality Suites (next to the Las Vegas Convention Center). GaN Systems will be demonstrating the latest designs in power supply, portable adapter, audio amplifier, wireless power, automotive solutions and more.

Please contact us online to reserve an appointment with senior management from GaN Systems at https://gansystems.com/ces-2020/.

About GaN Systems

GaN Systems is the global leader in GaN power semiconductors with the largest portfolio of transistors that uniquely address the needs of today's most demanding industries including data center servers, renewable energy systems, automotive, industrial motors and consumer electronics.

As a market-leading innovator, GaN Systems makes possible the design of smaller, lower cost, more efficient power systems. The company's award-winning products provide system design opportunities free from the limitations of yesterday's silicon. By changing the rules of transistor performance, GaN Systems is enabling power conversion companies to revolutionize their industries and transform the world. For more information, please visit: www.gansystems.com or on Facebook, Twitter and LinkedIn.

About Consumer Technology Association (CTA)®

CES showcases more than 4,500 exhibiting companies, including manufacturers, developers and suppliers of consumer technology hardware, content, technology delivery systems and more; a conference program with more than 250 conference sessions and more than 170,000 attendees from 160 countries.

And because CES is owned and produced by the Consumer Technology Association (CTA)® – the technology trade association representing the $401 billion U.S. consumer technology industry – it attracts the world's business leaders and pioneering thinkers to a forum where the industry's most relevant issues are addressed.

Media Inquiries:
Trier and Company
Mary Placido
mary@triercompany.com
415-218-3627

Sales Inquiries:
GaN Systems
Paul Wiener
PWiener@gansystems.com
510-299-1163

SOURCE: GaN Systems

ReleaseID: 569695

Charles F. D’agostino Joins RedHawk Board

LAFAYETTE, LA / ACCESSWIRE / December 10, 2019 / RedHawk Holdings Corp. (OTC PINK:SNDD) ("RedHawk" or the "Company") announced today that Charles F. D'Agostino has been appointed to its Board of Directors effective immediately.

Mr. D'Agostino is the retired founder and Executive Director of the LSU Innovation Park and the Louisiana Business & Technology Center ("LBTC") at Louisiana State University and has been actively involved in entrepreneurship, economic development and technology transfer for the last 30 years. While overseeing the LBTC, Mr. D'Agostino directed the five LSU Business Incubators, LSU rural and disaster business counseling programs, and the Louisiana Technology Transfer Office.

Mr. D'Agostino currently serves as vice-chairman of the Board of Trustees of the Baton Rouge General Hospital. Previously, he served on the Board of Directors of the Association of University Research Parks (1999-2005 and 2011-17) and was President from 2015 to 2017. He also served on the board of the National Business Incubation Association from 1991 to 1998. Mr. D'Agostino was given the Lifetime Achievement Award by the National Business Incubation Association in 2011 and the AURP Career Achievement Award in 2018. His awards and accomplishments also include:

2018 Career Achievement Award – Association of University Research Parks;
International Economic Development Council's Higher Education Committee (2010-2012);
2010 Fulbright Specialist in Economic Development;
Commissioner of the Greater Baton Rouge Port Commission (1996-2005); and
Small Business Administration – Advocate of the Year in Louisiana (1992).

Mr. D'Agostino received a Bachelor of Science for Arts & Science degree from Louisiana State University with a concentration in Chemistry. In 1972, Mr. D'Agostino also received a Masters of Business Administration degree from Louisiana State University.

"We are pleased to welcome Charlie as a new independent director to our board. He is joining RedHawk at an exciting time," said G. Darcy Klug, RedHawk's Chairman and Interim Chief Executive Officer. "We've worked with Charlie and his team at the LSU Innovation Center from the outset – starting with the engineering redesign of the SANDD™ line of products and continuing with the installation and initial testing of the Centri Controlled Entry System. Charlie is well respected in both technology and economic enterprise development and will be a tremendous asset to our business development as we continue to execute our business plan."

About RedHawk Holdings Corp.

RedHawk Holdings Corp., formerly Independence Energy Corp., is a diversified holding company which, through its subsidiaries, is engaged in sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services. Through its medical products business unit, the Company sells the Sharps and Needle Destruction Device (SANDD™), WoundClot Surgical – Advanced Bleeding Control, and the Carotid Artery Digital Non-Contact Thermometer. Through our United Kingdom based subsidiary, we manufacture and market branded generic pharmaceuticals. RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System, a unique, closed cabinet, nominal dose transmission full-body x-ray scanner.

Cautionary Statement Regarding Forward-Looking Statements

This release may contain forward-looking statements. Forward-looking statements are all statements other than statements of historical fact. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. The words "anticipate," "may," "can," "plans," "believes," "estimates," "expects," "projects," "targets," "intends," "likely," "will," "should," "to be," "potential" and any similar expressions are intended to identify those assertions as forward-looking statements.

Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties. In evaluating forward-looking statements, you should consider the various factors which may cause actual results to differ materially from any forward-looking statements including those listed in the "Risk Factors" section of our latest 10-K report. Further, the Company may make changes to its business plans that could or will affect its results. Investors are cautioned that the Company will undertake no obligation to update any forward-looking statements.

Company Contacts:

G. Darcy Klug, Chairman, CEO and CFO
(337) 269-5933
darcy.klug@redhawkholdingscorp.com

Investor Relations:

Stephanie Prince, Managing Director
PCG Advisory
(646) 762-4518
sprince@pcgadvisory.com

SOURCE: RedHawk Holdings Corp.

ReleaseID: 569664

DECN to Immediately Take Control of Two Market Ready, FDA Cleared, Glucose Monitoring Systems to Augment Its Primary Marketplace Positions

Company Adding A Low End System For Sale On Amazon, Walmart & Other Sites, While Second System With A Multi-Patient Monitor Is Perfect For Nursing Homes & Clinics

LOS ANGELES, CA / ACCESSWIRE / December 10, 2019 / Decision Diagnostics Corp. (OTCPINK:DECN) is a 17-year old, diabetes-focused bio-technology development firm, manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for the GenUltimate! ("Sunshine") diabetes test strip, the GenSure! ("Feather") diabetes test strip for International markets, and its GenChoice! ("Ladybug") test strip now in FDA 510(k) prosecution. The company also markets its PetSure! test strip for the diabetic testing of dogs and cats, a diagnostic specifically designed to run on the market leading Zoetis Alpha Trak meter system and the GenUltimate! 4Pets Test strip and Avantage! meter a proprietary testing product for dogs, cats and horses, and the panacea GenUltimate! TBG ("Dragonfly") diabetes testing system, now awaiting a clinical trial slot in Korea.

DECN announces today that we have decided to import and take control of two products that will round out our product lines in anticipation of our highly anticipated GenUltimate TBG products. The first product, which we named GenAccord! Is a practical FDA cleared lower end product that will be sold on amazon, Walmart and other e-commerce sites. We also anticipate private label and wholesale market to develop. GenAccord! will have a private label equivalent to be sold under the label Advant!

Keith Berman, CEO of DECN commented, "We have been in discussions with both a Korean and a Taiwanese manufacturer, each long standing and viable companies, for the import of a low end product already cleared by the FDA for U.S. sales and approved for CE Mark for European sales. Carrying the DECN brand enhances these products, which are immediately ready for sale in 1Q 2020. No investment in further development is required, which was a prerequisite."

In addition to the lower market end system GenAccord!, the company is also going to add a second system cleared by the FDA for multi-patient use. Multi-patient meters are required where the setting is a nursing home, clinic or health fair. This system will be distributed by a partner.

Mr. Berman continued, "While we have been very successful with our GenUltimate! products, we have lacked the development resources to produce additional niche products. And while we appear to have a big winner and successful potential partner for our TBG products, we lack marketing muscle. Often we have to choose between attendance at trade shows, or buying media advertising. Our most recent products, GenUltimate! TBG and now GenAccord! have succeeded in ‘threading the needle.' On the one hand, GenUltimate! TBG will be joint marketed on a licensing basis where we do not have to invest resources into sales and marketing, and the GenAccord! products are FDA cleared and market ready, and do not require any investment except to create packaging materials."

Mr. Berman concluded, "We have asked our partner to provide a "cocktail napkin" forecast and guaranteed minimum purchases for GenUltimate TBG and we will post most of this information as soon as it is adopted by both companies. As for GenAccord! we are pleased to announce that we anticipate selling an expected thousands of meters each month on Amazon and Walmart at $8.95 per meter ("buy two and keep a spare"), with each customer looking at a 60 day supply of test strips for $49.95. Of course, more about this in the coming days. We will post our forecast.

ABOUT DECISION DIAGNOSTICS CORP

Decision Diagnostics Corp. is the leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters. DECN's products are designed to operate efficiently and less expensively on certain glucose meters already in use by almost 7.5 million diabetics worldwide. With new inspired technology diabetic test strips already in the final stages of development, DECN products compete on a worldwide scale with legacy manufacturers currently selling to 71+ percent of a $15+ billion at-home testing market. The company's GenUltimate TBG product is not yet available for sale in the United States or Puerto Rico but is expected to go on sale in select International markets in January 2020.

Forward-Looking Statements:

This release contains the company's forward-looking statements which are based on management's current expectations and assumptions as of December 9, 2019 regarding the company's business and performance, its prospects, current factors, the economy, and other future conditions and forecasts of future events, circumstances, and results.

CONTACT INFORMATION:

Decision Diagnostics Corp.
Keith Berman (805) 446-2973

info@decisiondiagnostics.co
www.genultimate.com
www.genultimatetbg.com

www.petsureteststrips.com
www.pharmatechdirect.com

SOURCE: Decision Diagnostics Corp.

ReleaseID: 569707

MMSI CLASS ACTION ALERT: Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against Merit Medical Systems, Inc.

NEW YORK, NY / ACCESSWIRE / December 10, 2019 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of Merit Medical Systems, Inc. ("Merit" or the "Company") (NASDAQ:MMSI) between February 26, 2019 and October 30, 2019, inclusive (the "Class Period"). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act of 1934.

If you purchased Merit securities, and/or would like to discuss your legal rights and options please visit Merit Shareholder Class Action or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

The complaint alleges that during the Class Period, defendants made false and misleading statements and/or failed to disclose adverse information concerning Merit's business and prospects. Specifically, defendants failed to disclose that: (a) the integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (b) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during fiscal 2019; and (c) in light of the foregoing, the Company's reported financial guidance for fiscal 2019 and 2020 was made without a reasonable basis.

On July 25, 2019, following the Company's second quarter 2019 financial results the Company held a conference call for analyst's and investors to discuss the results. On that call Defendants admitted that the miss and guidance reduction were in part due to the fact that ClariVein had zero orders for the first half of the year due to pipeline filling prior to the acquisition.

Following these disclosures the Company's stock price fell more than 25% from a close of $54.84 per share on July 25, 2019, to a close of $41.00 per share on July 26, 2019, on volume of more than 6.2 million shares.

Then, on October 30 2019, after the market closed, the Company issued a press release announcing the Company's third quarter 2019 financial results. The Company disclosed significant operational issues in all aspects of Merit's business. Defendants admitted that they were months behind in their integration of Cianna and Vascular Insights, their integration of R&D facilities was too expensive and had necessitated a 2% to 5% reduction in headcount, and that they had to take a material revenue recognition adjustment in the quarter.

Following this disclosure, Merit's stock price declined more than 29%, from a close of $29.11 per share on October 30, 2019, to a close of $20.66 per share on October 31, 2019.

If you purchased Merit securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/meritmedicalsystems-mmsi-shareholder-investigation-stock-fraud-lawsuit-169/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

If you wish to serve as lead plaintiff, you must move the Court no later than February 3, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2019 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
MGuarnero@bernlieb.com

SOURCE: Bernstein Liebhard LLP

ReleaseID: 569178

CounterPath Launches Bria Solo, Extending Business-Class Calling on Desktop and Mobile Devices

New VoIP softphone solution replaces X-Lite and Bria 5 products

VANCOUVER, BC / ACCESSWIRE / December 10, 2019 / CounterPath Corporation (NASDAQ:CPAH)(TSX:PATH), a global provider of award-winning Unified Communications and Collaboration (UCC) solutions for enterprises and service providers, today announced the launch of Bria Solo, a next-generation softphone that combines business-class communication features, such as HD voice and video calling, in a user-friendly interface to help people seamlessly transition from a traditional phone environment to the world of Voice over IP (VoIP). Bria Solo will be available as a free version to replace CounterPath's flagship X-Lite softphone and also as a premium, enhanced version on a subscription basis to replace the Bria 5 softphone solution.

Bria Solo offers individuals looking for a standalone softphone with a unique opportunity to test drive a world-renowned voice, video, messaging and presence application on both desktop and mobile devices. Securely configured and managed from the cloud, Bria Solo includes an easy to use web portal in which users can set up their voice accounts once and then simply login to their Bria application on Windows, Mac, iOS or Android with their username and password to start communicating.

"Over the last decade, our popular X-Lite and Bria products set the standards for high-quality softphones. We are excited to debut Bria Solo – an offering that replaces both products with a single solution that elevates the user experience by centralizing the management of up to three devices for individual users," said Todd Carothers, Chief Revenue Officer at CounterPath. "We are proud to continue our tradition of being a market leader in providing differentiated product innovations focused on meeting the ever-changing business and technology requirements of our users and delivering the features and functionality that today's modern, collaborative workforce needs to be competitive."

Bria Solo features include (note the free version of Bria Solo may differ):

Voice service and call server compatibility with the highest range of ITSP, VoIP, PBX and UC vendors in the market
Support for up to five calling accounts
Up to three application downloads on Windows, Mac, iOS or Android devices, with configured services synced across apps
HD voice and video calling support across devices
Advanced call management features including auto-answer, call recording, call transfer, call merge and call hold
A comprehensive call history that is synced across applications, including the ability search and sort through calls and call recordings

Users can experience all of the features of Bria Solo free for 30 days by visiting www.counterpath.com/plan-select-solo/. Once their free trial has ended, they can choose to either purchase a subscription or are automatically enrolled in Bria Solo Free, a solution experience comparable to X-Lite. Bria Solo Free is limited to a single voice account and device, as well as some call management features, but retains the same user-friendly interface. Users of Bria Solo Free can upgrade to Bria Solo at any time, and all of their settings and accounts are saved within their portal, making the process seamless to transition back to a subscribed account.

With the Bria Solo subscription solution, users not only get mobile apps included, they receive all upgrades and updates as a part of their subscription as well, aligning to consumer expectations in modern software products.

For more information about Bria Solo and Bria Solo Free, please visit www.counterpath.com/bria-solo.

About Bria Solo

Bria Solo is an easy to use softphone solution that integrates with any call server (PBX) or VoIP service, allowing users to take their business number with them as their single identity. Supporting HD voice and video calling, and intuitive call management features, users have access to business-class communication tools from their desktop and mobile devices, staying connected on any device, anywhere and over any network.

About CounterPath

CounterPath Corporation (NASDAQ: CPAH) is revolutionizing how people communicate in today's modern mobile workforce. Its award-winning Bria solutions for desktop and mobile devices enable organizations to leverage their existing PBX and hosted voice call servers to extend seamless and secure unified communications and collaboration services to users regardless of their location and network. CounterPath technology meets the unique requirements of several industries, including the contact center, retail, warehouse, hospitality, and healthcare verticals. Its solutions are deployed worldwide by 8×8, Airbnb, AmeriSave, BT, Citibank, Comcast, Fusion, Fuze, Liberty Global, Uber, Windstream and others. Learn more at counterpath.com and follow on Twitter @counterpath.

Contacts

Hanna Miller
Vice President, Marketing
hmiller@counterpath.com

Investor Relations
ir@counterpath.com

SOURCE: CounterPath Corporation

ReleaseID: 569698

MinKap Resources Inc. and Ubique Minerals Inc. Amend Option Agreement for Daniel’s Harbour Property, Newfoundland

TORONTO, ON / ACCESSWIRE / December 10, 2019 / MinKap Resources Inc. (TSXV:KAP) (the "Company") and Ubique Minerals Limited (CSE:UBQ) ("Ubique") announce that they have agreed to modify the terms of the previously announced option agreement (the "Option Agreement") for the Daniel's Harbour property located in Newfoundland (the "Property") with respect to the timing of certain work and payment commitments.

The Option Agreement has been revised as per the table below:

Date/Period

Amounts Payable

Shares

Expenditure

On signing of this Agreement, which date being February 13th, 2019

$10,000

500,000

 

On or before March 9, 2019

 
 

$12,000 and file a work assessment report

On or before September 15, 2019

 
 

an additional $88,000 (for a total of $100,000)

On or before the date that is 1 year from the date of the signing of this Agreement i.e. February 12th, 2020

additional $10,000

additional 500,000

 

On or before the date that is 2 years from the date of the signing of this Agreement, i.e. February 12th, 2021

 

additional 200,000

 

On or before February 28, 2021

 
 

an additional $200,000 (for a total of $300,000)

On or before September 1st, 2021

 
 

$40,000 cash payment for the payment to the Vendors from whom KAP optioned the property

On or before February 28, 2022

 
 

an additional $300,000 (for a total of $600,000), which amounts include payments to the Vendors from whom KAP optioned the property

On or before the expiration of Year 5, i.e. February 12th, 2024

 
 

$400,000

On completion of all the conditions outlined in the table above, Ubique will have earned an undivided 55% interest in the Property. Thereafter the Option Agreement provides for Ubique to earn an additional 15% interest, the terms of which acquisition have not changed from those in the original Option Agreement.

On behalf of the Board of Directors MinKap Resources Inc.
Jonathan Armes
President & CEO
Phone 1 (416) 708-0243

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

This press release contains forward-looking statements within the meaning of applicable Canadian and U.S. securities laws and regulations, including statements regarding the future activities of the Company. Forward looking statements reflect the current beliefs and expectations of management and are identified by the use of words including "will", "anticipates", "expected to", "plans", "planned" and other similar words. Actual results may differ significantly. The achievement of the results expressed in forward-looking statements is subject to a number of risks, including those described in the Company's management discussion and analysis as filed with the Canadian securities regulatory authorities which are available at www.sedar.com. Investors are cautioned not to place undue reliance upon forward-looking statements.

SOURCE: MinKap Resources Inc.

ReleaseID: 569619

Powerbridge Technologies Awarded Contract to Provide Smart Zone Solutions for Hefei Integrated Special Regulated Zone for Bonded Goods

Significant Strategic Milestone in Expanding into Anhui Province in Eastern China

ZHUHAI, CHINA / ACCESSWIRE / December 10, 2019 / Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) ("Powerbridge" or the "Company"), a global trade software applications and technology services provider, today announced that the Company was successfully granted the Bid to provide Powerbridge Smart Zone Solutions to Hefei Integrated Special Regulated Zone for Bonded Goods ("H-Zone"). H-Zone was one of the strategic pilot zones established for expanding China's cross-border eCommerce business. H-Zone was also designated as the Provincial Cross-border eCommerce Industrial Zone in 2018.

As part of the Company's continued market development effort, winning of the H-Zone Bid serves as an important and strategic milestone in expanding into Anhui Province in Eastern China. Powerbridge Smart Zone Solutions will help streamline process operations and enhance overall efficiency for H-Zone, particularly for cross-border eCommerce operations in compliance and logistics.

Stewart Lor, President and Chief Financial Officer, commented, "We are very pleased with winning the bid for H-Zone to provide our Smart Zone Solutions. This is an important step in our continued market development effort in expanding into new geographical markets with our new products and solutions. We are confident that the H-Zone project will serve as a proven "sample case" to generate more business opportunities in Anhui Province, as we expect it to start generating revenue for us in early 2020."

Additionally, Powerbridge successfully executed a strategic partnership with Kebao Culture & Technology Co., Ltd. ("Kebao") to collaborate on product and business development, leveraging the combined strengths of Kebao and Powerbridge in big data, mobile and blockchain technologies. Kebao is a big data and mobile technology driven company specializing in driving business value chains for cross-border eCommerce businesses, particularly for enhancing user traffic values and multi-player trust mechanisms.

About Powerbridge

Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) is a provider of software applications and technology solutions and services to corporate and government customers primarily located in China. Founded in 1997, Powerbridge pioneered global trade software applications with a vision to make global trade operations easier for customers. Since inception, Powerbridge has continued to innovate and deliver solutions and services to address the changing needs of thousands of customers. Powerbridge's mission is to make global trade easier by empowering all players in the ecosystem. For more information, visit www.powerbridge.com/en

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements; specifically, the Company's statements regarding listing on the NASDAQ Capital Market and the IPO are forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

Corporate:

Powerbridge Technologies Co., Ltd.
Stewart Lor
President and Chief Financial Officer
Email: stewartlor@powerbridge.com

Investor Relations:

Hayden IR
Stephen Hart
Phone: 917-658-7878
Email: hart@haydenir.com

SOURCE: Powerbridge Technologies Co., Ltd.

ReleaseID: 569728

Youngevity International, Inc to Present at the 12th Annual LD Micro Main Event -YGYI is Sponsor of LD Micro Event

LOS ANGELES, CA / ACCESSWIRE / December 10, 2019 / Youngevity International, Inc. (NASDAQ:YGYI), a leading multi-channel lifestyle company, today announced that it will be presenting at the 12th annual LD Micro Main Event on Wednesday, December 11 at 11:20 AM PST / 2:20 PM EST. Dave Briskie (President/CFO of Youngevity International) will be presenting YGYI to various institutional investors, family offices, and high net worth investors.

"LD Micro continues to be an integral part of our awareness campaign and we are proud to be a premier sponsor, once again, for this year's Main Event.", said Dave Briskie, President and Chief Financial Officer of Youngevity.

Youngevity is also pleased to be a premier sponsor of this event featuring Be the Change™ coffee and Josies Java House Coffee, two of the company owned brands. YGYI coffee is field to cup, grown on our own plantation in the Nicaraguan rainforest and roasted at CLR Roasters, our wholly owned subsidiary, located in Miami, Florida. Our fully sustainable, Rainforest Alliance, and Organic Certified coffee will be proudly served to all attending the conference.

The Youngevity presentation will be webcast and can be followed at http://wsw.com/webcast/ldmicro17/ygyi/. The webcast will be available for view for 90 days following the live presentation.

"This year's Main Event is our largest event to date, with 275 companies set to present and meet with investors" stated Chris Lahiji, President of LD Micro. "Even though LD has emerged as one of the largest and most influential organizations in the space, our focus has never deviated from showcasing some of the more interesting businesses in the world to our ever-growing community. Investor interest in our events has also never been stronger, and that goes for our commitment to philanthropy as well."

The LD Micro Main Event will take place on December 10th-12th in Los Angeles, at the Luxe Sunset Bel Air Hotel, which will feature 275 companies, and will be attended by over 1,400 individuals.

View Youngevity's profile here: https://www.ldmicro.com/profile/YGYI

About Youngevity International, Inc

YGYI, Inc. (NASDAQ: YGYI), is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity YGYI offers products from the eight top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The Company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company's food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.

To receive future press releases via email, please visit: https://ygyi.com/investors/email-alerts/

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space.

What started out as a newsletter highlighting unique companies has transformed into several influential events annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. These forward-looking statements are based on management's expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, our ability to continue our hemp segment growth, our ability to continue our coffee segment growth, our ability to continue our international growth, our ability to leverage our platform and global infrastructure to drive organic growth, our ability to improve our profitability, expand our liquidity, and strengthen our balance sheet, our ability to continue to maintain compliance with the NASDAQ requirements, the acceptance of the omni-direct approach by our customers, our ability to expand our distribution, our ability to add additional products (whether developed internally or through acquisitions), our ability to continue our financial performance and the other factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2018 and our subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Contacts:

Youngevity International, Inc.
Dave Briskie
President and Chief Financial Officer
800-982-3189 X6500

Investor Relations
YGYI Investor Relations
800-504-8650
investors@ygyi.com

SOURCE: Youngevity International, Inc.

ReleaseID: 569710